Alesta Therapeutics
Recent news mentioning Alesta Therapeutics
- — BioMarin Announces Close of the Alesta Therapeutics Acquisition
- — BioMarin acquiring Alesta Therapeutics for $275 million
- — BioMarin Shares Jump After $275 Million Deal to Acquire Alesta Therapeutics
- — BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin's Pipeline